Wednesday, February 10, 2010, 2:35am EST - Canadian Markets open in 6 hours and 55 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

Hospira Inc. (HSP)

 On Feb 9: 49.42 USD  Up 0.66 (1.35%)  
MORE ON HSP
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
HOSPIRA INC (NYSE:HSP) Delayed quote dataEdit
After Hours: 49.59 Up 0.17 (0.35%) as of 5:00pm EST on 02/09/10
Last Trade: 49.42 USD
Trade Time: Feb 9
Change: Up 0.66 (1.35%)
Prev Close: 48.76
Open: 49.17
Bid: N/A
Ask: N/A
1y Target Est: 48.50
Day's Range: 48.99 - 50.13
52wk Range: 21.21 - 52.79
Volume: 777,727
Avg Vol (3m): 807,232
Market Cap: 8.01B
P/E (ttm): 72.78
EPS (ttm): 0.68
Div & Yield: N/A (N/A%)
Hospira Inc. (HSP)
1d  5d  3m  6m  1y  2y  5y  max 
Free Annual Reports
 Add HSP to Portfolio   Download Data

HEADLINES
• ChemGenex: A Snow-Fueled Setback at the FDA
at Seeking Alpha (Tue 1:33pm)
• UPDATE - U.S. FDA staff questions small ChemGenex study
at Reuters (Mon, Feb 8)
• In Pictures: Five Small- And Mid-Cap Buys
at Forbes.com (Mon, Feb 8)
• UPDATE - U.S. FDA staff questions small ChemGenex study
at Reuters (Mon, Feb 8)
• New Star Analyst Rankings for HOSPIRA INC
StarMine (Sat, Feb 6)
• Hospira Inc Q4 2009 Earnings Call Transcript
at Seeking Alpha (Thu, Feb 4)
• Hospira Surges Ahead
Zacks.com (Thu, Feb 4)
• [$$] Hospira Profit Falls, But Sales Jump On Generic Chemo Drug
at The Wall Street Journal Online (Thu, Feb 4)
• Hospira 4Q profit slips 8 percent on charges
AP (Thu, Feb 4)
• UPDATE - Hospira beats St view by far, but shares slip
at Reuters (Thu, Feb 4)
• HOSPIRA INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
EDGAR Online (Thu, Feb 4)
• Hospira fourth-quarter profit declines
at MarketWatch (Thu, Feb 4)
More Headlines for HSP...
ANALYST
EPS Est (next year) (Dec-07) : N/A
EPS Est (in 2 years) (Dec-08) : N/A
Avg Rec (current)*: 2.2
PEG Ratio: N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
Hospira, Inc. engages in the development, manufacture, and marketing of specialty injectable pharmaceuticals and medication delivery systems that deliver drugs and intravenous (I.V.) fluids in the United States and internationally.

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices